| Item Type | Name |
|
Concept
|
HLA-C Antigens
|
|
Concept
|
HLA-B Antigens
|
|
Concept
|
HLA-A Antigens
|
|
Concept
|
HLA Antigens
|
|
Concept
|
HLA-DP Antigens
|
|
Concept
|
HLA-DQ Antigens
|
|
Concept
|
HLA-DR Antigens
|
|
Concept
|
HLA-A2 Antigen
|
|
Academic Article
|
High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.
|
|
Academic Article
|
Outcomes of patients with myeloid malignancies treated with allogeneic hematopoietic stem cell transplantation from matched unrelated donors compared with one human leukocyte antigen mismatched related donors using HLA typing at 10 loci.
|
|
Academic Article
|
Donor-specific anti-HLA Abs and graft failure in matched unrelated donor hematopoietic stem cell transplantation.
|
|
Academic Article
|
Adenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience.
|
|
Academic Article
|
Multiple mismatches at the low expression HLA loci DP, DQ, and DRB3/4/5 associate with adverse outcomes in hematopoietic stem cell transplantation.
|
|
Academic Article
|
Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.
|
|
Academic Article
|
Allogeneic bone marrow transplants for Fanconi anemia. A preliminary report from the International Bone Marrow Transplant Registry.
|
|
Academic Article
|
The role of bone marrow transplantation for nuclear accidents: implications of the Chernobyl disaster.
|
|
Academic Article
|
Sustained recovery of hematopoiesis and immunity following transplantation of fetal liver cells in dogs.
|
|
Academic Article
|
Transplantation of T lymphocyte depleted bone marrow to prevent graft-versus-host disease: its implications for fetal liver transplantation.
|
|
Academic Article
|
Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia.
|
|
Academic Article
|
Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients.
|
|
Academic Article
|
CD25 expression on donor CD4+ or CD8+ T cells is associated with an increased risk for graft-versus-host disease after HLA-identical stem cell transplantation in humans.
|
|
Academic Article
|
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.
|
|
Academic Article
|
Identifying candidate allogeneic NK-cell donors for hematopoietic stem-cell transplantation based on functional phenotype.
|
|
Academic Article
|
Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes.
|
|
Academic Article
|
Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies.
|
|
Academic Article
|
Second HLA-identical sibling transplants for leukemia recurrence.
|
|
Academic Article
|
Bone marrow transplantation utilizing HLA-matched unrelated marrow donors.
|
|
Academic Article
|
Case problems in bone marrow transplantation. I. Graft failure in aplastic anemia: its biology and treatment.
|
|
Academic Article
|
Evaluation of anti-CD5 ricin A chain immunoconjugate for prevention of acute graft-vs.-host disease after HLA-identical marrow transplantation.
|
|
Academic Article
|
T-cell depletion for allogeneic bone marrow transplantation: impact on graft-versus-host disease, engraftment, and graft-versus-leukemia.
|
|
Academic Article
|
Identical-twin bone marrow transplants for leukemia.
|
|
Academic Article
|
Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?
|
|
Academic Article
|
Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program.
|
|
Academic Article
|
A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia.
|
|
Academic Article
|
Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation.
|
|
Academic Article
|
Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.
|
|
Academic Article
|
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia.
|
|
Academic Article
|
Should HLA-identical sibling bone marrow transplants for leukemia be restricted to large centers?
|
|
Academic Article
|
Bone marrow transplantation for severe aplastic anemia.
|
|
Academic Article
|
Bone marrow transplantation in acute leukaemia.
|
|
Academic Article
|
Treatment of acute myelogenous leukemia. A prospective controlled trial of bone marrow transplantation versus consolidation chemotherapy.
|
|
Academic Article
|
Aplastic anemia: biology and treatment.
|
|
Academic Article
|
Role of bone marrow transplantation in the treatment of hematologic malignancies and solid tumors: critical review of syngeneic, autologous, and allogeneic transplants.
|
|
Academic Article
|
Large-scale preparation of highly purified, frozen/thawed CD34+, HLA-DR- hematopoietic progenitor cells by sequential immunoadsorption (CEPRATE SC) and fluorescence-activated cell sorting: implications for gene transduction and/or transplantation.
|
|
Academic Article
|
Bone marrow transplantation for leukemia utilizing HLA-matched unrelated donors.
|
|
Academic Article
|
Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.
|
|
Academic Article
|
HLA-identical sibling bone marrow transplants vs chemotherapy for acute myelogenous leukemia in first remission.
|
|
Academic Article
|
Tacrolimus and minidose methotrexate for prevention of acute graft-versus-host disease after HLA-mismatched marrow or blood stem cell transplantation.
|
|
Academic Article
|
Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
|
|
Academic Article
|
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.
|
|
Academic Article
|
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.
|
|
Academic Article
|
Autologous blood cell transplantation versus HLA-identical sibling transplantation for acute myeloid leukemia in first complete remission: a registry study from the Center for International Blood and Marrow Transplantation Research.
|
|
Academic Article
|
Toward eliminating HLA class I expression to generate universal cells from allogeneic donors.
|
|
Academic Article
|
HLA-DP incompatibilities and severe graft-versus-host disease in unrelated bone marrow transplants.
|
|
Academic Article
|
T-cell depletion of HLA-identical transplants in leukemia.
|
|
Academic Article
|
Effect of recombinant human granulocyte-macrophage colony-stimulating factor administration on the lymphocyte subsets of patients with refractory aplastic anemia.
|
|
Academic Article
|
Graft failure and graft-vs-host disease after subtotal T-cell-depleted marrow transplantation: correlations with marrow hematopoietic and lymphoid subsets.
|
|
Academic Article
|
Bone marrow transplantation from HLA-matched unrelated donors as treatment for leukemia.
|
|
Academic Article
|
Outcomes of patients treated and one human leukocyte antigen-mismatched related compared with matched unrelated donors.
|
|
Academic Article
|
Effect of donor-recipient HLA matching at HLA A, B, C, and DRB1 on outcomes after umbilical-cord blood transplantation for leukaemia and myelodysplastic syndrome: a retrospective analysis.
|
|
Academic Article
|
Bone marrow transplantation for chronic myelogenous leukemia.
|
|
Academic Article
|
How does bone-marrow transplantation cure leukaemia?
|
|
Academic Article
|
Bone marrow transplantation from unrelated donors.
|
|
Academic Article
|
The impact of T-cell depletion on the effects of HLA DR beta 1 and DQ beta allele matching in HLA serologically identical unrelated donor bone marrow transplantation.
|
|
Academic Article
|
Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation.
|
|
Academic Article
|
Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?
|
|
Academic Article
|
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.
|
|
Academic Article
|
Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia.
|
|
Academic Article
|
Haploidentical Hematopoietic Stem Cell Transplantation as a Platform for Post-Transplantation Cellular Therapy.
|
|
Academic Article
|
Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation.
|
|
Academic Article
|
Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application.
|
|
Academic Article
|
Genetic editing of HLA expression in hematopoietic stem cells to broaden their human application
|
|
Academic Article
|
Are changes in HLA Ags responsible for leukemia relapse after HLA-matched allogeneic hematopoietic SCT?
|
|
Academic Article
|
Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation
|
|
Academic Article
|
Specific combinations of donor and recipient KIR-HLA genotypes predict for large differences in outcome after cord blood transplantation
|
|
Academic Article
|
Proceedings from the Second Haploidentical Stem Cell Transplantation Symposium-Haplo2014, San Francisco, California, December 4, 2014.
|
|
Academic Article
|
PR1 peptide vaccine induces specific immunity with clinical responses in myeloid malignancies.
|
|
Academic Article
|
HLA-mismatched bone marrow transplantation in severe aplastic anemia.
|
|
Academic Article
|
Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center.
|
|
Academic Article
|
Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion.
|
|
Academic Article
|
Pilot study using post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate GVHD prophylaxis for older patients receiving 10/10 HLA-matched unrelated donor hematopoietic stem cell transplantation.
|
|
Academic Article
|
HLA-DP mismatch and CMV reactivation increase risk of aGVHD independently in recipients of allogeneic stem cell transplant.
|
|
Concept
|
HLA-DR beta-Chains
|
|
Concept
|
HLA-DRB1 Chains
|
|
Concept
|
HLA-DRB3 Chains
|
|
Concept
|
HLA-DRB4 Chains
|
|
Concept
|
HLA-DRB5 Chains
|
|
Concept
|
HLA-DP beta-Chains
|
|
Academic Article
|
Molecular disparity in human leukocyte antigens is associated with outcomes in haploidentical stem cell transplantation.
|
|
Academic Article
|
GMP-Compliant Universal Antigen Presenting Cells (uAPC) Promote the Metabolic Fitness and Antitumor Activity of Armored Cord Blood CAR-NK Cells.
|
|
Academic Article
|
Refined HLA-DPB1 mismatch with molecular algorithms predicts outcomes in hematopoietic stem cell transplantation.
|
|
Academic Article
|
Treatment of allosensitized patients receiving allogeneic transplantation.
|
|
Academic Article
|
Mycophenolate Mofetil: A Friend or a Foe with Post-Transplantation Cyclophosphamide and Tacrolimus Prophylaxis in HLA-Matched Donors?
|
|
Academic Article
|
A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study.
|
|
Academic Article
|
Post-Transplantation Cyclophosphamide Versus Tacrolimus and Methotrexate Graft-Versus-Host Disease Prophylaxis for HLA-Matched Donor Transplantation.
|
|
Academic Article
|
HLA Factors versus Non-HLA Factors for Haploidentical Donor Selection.
|
|
Academic Article
|
Molecular disparity of HLA-DPB1 is associated with the development of subsequent solid cancer after allogeneic hematopoietic stem cell transplantation.
|